Abiopharma

Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST

UTHR: Notification

XOMA Royalty Enters into Agreement to Acquire Generation Bio

XOMA Royalty Enters into Agreement to Acquire Generation Bio

Accuray announces first phase of comprehensive strategic, operational, and organizational transformation plan; company expects first phase to improve annualized operating profitability by approximately $25 million and set the stage for renewed growth

Perimeter Solutions Prices Offering of $550 Million of Senior Secured Notes Due 2034

Notification from Dominari Holdings Inc

HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

Cellectis Announces Arbitral Decision in Dispute with Servier

BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec